Clinical Trial Update: Urine CXCL10 Monitoring Trial in Kidney Transplant [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 2/3 study evaluating urine CXCL10 monitoring in kidney transplant patients to help detect or predict rejection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant
• Renal Transplant Rejection

Snippet

Sponsor: University of Manitoba | Conditions: Kidney Transplant; Complications, Rejection of Renal Transplant | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING